ネットワーク薬理学と分子ドッキングアプローチによる川崎病の治療におけるダンシェンのメカニズムを探求

Aiyuan Cai¹, Huishi Ye², Yuanhong Lin³

¹Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong Province, China.

Medicine

|September 3, 2025

まとめ

この研究は,川崎病 (KD) の治療におけるDanshenの活性成分と標的を明らかにしています. 多様な経路で作用し,KDの治療に抗炎症と抗動脈硬化作用をもたらすことが示唆されています.

科学分野:

薬理学について
システム生物学
中国伝統医学

背景:

カワサキ病 (KD) は,重大な小児疾患である.
ダンシェン (Salvia miltiorrhiza) は,潜在的な治療効果を持つ伝統的な中国薬である.

研究の目的:

ダンシェンの活性成分と標的を特定する
カワサキ病の治療におけるダンシェンのメカニズムを解明する.

主な方法:

システム薬理学およびバイオ情報学データベース (SwissTargetPrediction,OMIMなど) 使用されました.
タンパク質とタンパク質の相互作用のネットワークと経路濃縮の分析が行われました.
分子ドッキングは相互作用を検証するために使用されました.

主要な成果:

70の潜在的薬標的と7つのコア遺伝子 (IL6,TNF,AKT1,BCL2,STAT3,CASP3,TP53) が特定されました.
濃縮分析でがん,動脈硬化,流体切断のストレス経路が明らかになった.
主要なダンシェン成分は,コア遺伝子を調節する可能性があることを示した.

結論:

ダンシェンはカワサキ病の治療に多要素・多標的戦略を用いる.
抗炎症,抗アポプトシス,抗腫瘍,抗動脈硬化効果を含む.
ダンシェンの有効性と KDの潜在的な治療目標の証拠を提示します.

キーワード:

ダンシェンカワサキ病抗炎症剤抗血小板薬ネットワーク薬理学

さらに関連する動画

08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

174

12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

898

関連する概念動画

01:28

Structure-Activity Relationships and Drug Design

1.0K

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

1.0K

01:27

Transducer Mechanism: Enzyme-Linked Receptors

2.8K

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

2.8K

01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

505

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

505

01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

673

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

673

01:21

Pharmacodynamics: Overview and Principles

2.0K

Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...

2.0K

01:23

Antihypertensive Drugs: Vasodilators

642

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...

642

関連する実験動画